Ever Source Wealth Advisors, LLC Avidity Biosciences, Inc. Transaction History
Ever Source Wealth Advisors, LLC
- $1.66 Billion
- Q1 2025
A detailed history of Ever Source Wealth Advisors, LLC transactions in Avidity Biosciences, Inc. stock. As of the latest transaction made, Ever Source Wealth Advisors, LLC holds 50 shares of RNA stock, worth $1,779. This represents 0.0% of its overall portfolio holdings.
Number of Shares
50
Previous 47
6.38%
Holding current value
$1,779
Previous $1,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding RNA
# of Institutions
244Shares Held
116MCall Options Held
289KPut Options Held
998K-
Janus Henderson Group PLC London, X011.4MShares$407 Million0.19% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD11.3MShares$404 Million0.04% of portfolio
-
Wellington Management Group LLP Boston, MA9.68MShares$345 Million0.06% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.24MShares$329 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY8.75MShares$311 Million4.23% of portfolio
About Avidity Biosciences, Inc.
- Ticker RNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,127,000
- Market Cap $1.86B
- Description
- Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat a range of serious diseases. The company's lead product candidate AOC 1001 is used for the treatment of myotonic dystrophy type 1, a rare monogenic...